vTv Therapeutics Inc expected to post a loss of 4 cents a share - Earnings Preview

vTv Therapeutics

04/11/2022 19:32

* vTv Therapeutics Inc  VTVT.OQ   VTVT.O  is expected
to show a
fall in quarterly revenue when it reports  results on November 7
(estimated). 
    * The High Point North Carolina-based  company is expected
to
report  a 91.7% decrease in revenue to $250 thousand from $3
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for vTv Therapeutics
Inc is
for a loss of 4 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for vTv
Therapeutics
Inc is $5​, above​ its last closing price of $0.84. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.09       -0.09      -0.04     Beat    55.6
 Mar. 31 2022  -0.08       -0.08      -0.10     Missed  -25
 Dec. 31 2021              -0.07      -0.11     Missed  -46.7​
 Sep. 30 2021  -0.09       -0.07      -0.02     Beat    71.4
 ​​Jun.        -0.07       -0.07      -0.01     Beat    85.7
 30 2021                                                
 Mar. 31 2021  -0.06       -0.06      -0.08     Missed  -33.3​
 Dec. 31 2020  -0.04       -0.05      0.02      Beat    136.4
 Sep. 30 2020  -0.03       -0.09      -0.03     Beat    68.4
 This summary was machine generated November 4 at 19:31 GMT.  All
figures in US dollars  unless otherwise stated